Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$878,706
-$60,303 QoQ
Shares Held
2,919
+2.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#416
of 784 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Siemens Fonds Invest GmbH holds $11,160,612 across 7 Biotechnology names. ALNY ranks #3 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,930 | $5,925,988 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,060 | $3,155,112 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
2,919 | $878,706 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
2,339 | $438,047 | |
| 5 | INCY |
Incyte Corp
|
3,670 | $416,031 | |
| 6 | INSM |
INSMED Inc
|
3,080 | $328,389 | |
| 7 | FTRE |
Fortrea Holdings Inc.
|
1,054 | $18,339 |
All Filings in ALNY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $878,706 | 2,919 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $939,009 | 2,838 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $730,483 | 1,837 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $837,672 | 1,837 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $600,983 | 1,843 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $397,199 | 1,471 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $321,198 | 1,365 | Shares | Sole | 2025-03-04 | |
| 2024-09-30 | $375,415 | 1,365 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||